intravenous immunoglobulin 10% solution

intravenous immunoglobulin · Baxalta (now part of Shire)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for intravenous immunoglobulin 10% solution, covering 2021-08-24 to 2021-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders [Phase 3]

See pricing